Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 2 Podocyte dysfunction is a common feature of renal injury

Published byJoel Allen Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 2 Podocyte dysfunction is a common feature of renal injury"— Presentation transcript:

1 Figure 2 Podocyte dysfunction is a common feature of renal injury
Figure 2 | Podocyte dysfunction is a common feature of renal injury. The podocytes of a | control mice and c | healthy people display primary and secondary processes with tertiary foot processes that interdigitate regularly with neighbouring podocytes. b | After adriamycin treatment, mice develop chronic kidney disease with characteristic foot process effacement. d | A representative glomerulus from a patient who experienced podocytopathy after an iatrogenic toxic renal injury, showing diffuse loss of podocyte cytoarchitecture, extensive foot process effacement and endothelial injury of the glomerular capillaries. Images are scanning electron micrographs. Perico, L. et al. (2016) Podocyte–actin dynamics in health and disease Nat. Rev. Nephrol. doi: /nrneph

Download ppt "Figure 2 Podocyte dysfunction is a common feature of renal injury"

Similar presentations

Figure 1 Schematic representation of idiopathic nephrotic syndrome,

Figure 1 Schematic representation of idiopathic nephrotic syndrome,
Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.

Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.
Figure 4 Interplay between acute kidney injury (AKI),

Figure 4 Interplay between acute kidney injury (AKI),
Figure 6 Effects of adiponectin on podocyte function

Figure 6 Effects of adiponectin on podocyte function
Figure 5 Inter-relationships between sleep apnoea, CKD and brain injury Figure 5 | Inter-relationships between sleep apnoea, CKD and brain injury. In chronic.

Figure 5 Inter-relationships between sleep apnoea, CKD and brain injury Figure 5 | Inter-relationships between sleep apnoea, CKD and brain injury. In chronic.
Figure 3 Energy metabolism regulation, cardiovascular and bone disease in CKD Figure 3 | Energy metabolism regulation, cardiovascular and bone disease.

Figure 3 Energy metabolism regulation, cardiovascular and bone disease in CKD Figure 3 | Energy metabolism regulation, cardiovascular and bone disease.
Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.

Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.
Figure 4 Expression of coagulation protease receptors in renal cells

Figure 4 Expression of coagulation protease receptors in renal cells
Figure 4 Interactions between adipose, the microbiome and kidney

Figure 4 Interactions between adipose, the microbiome and kidney
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Mechanisms of kidney injury in the setting of obesity

Figure 1 Mechanisms of kidney injury in the setting of obesity
Figure 2 Physiological changes in the renal system in pregnancy

Figure 2 Physiological changes in the renal system in pregnancy
Figure 2 Proinflammatory mechanisms in CKD

Figure 2 Proinflammatory mechanisms in CKD
ANCA Associated Vasculitis Secondary to Levamisole-Adultered Cocaine with Associated Membranous Nephropathy: A Case Series Collister et al. Am J Nephrol.

ANCA Associated Vasculitis Secondary to Levamisole-Adultered Cocaine with Associated Membranous Nephropathy: A Case Series Collister et al. Am J Nephrol.
Figure 1 Pathological features of lupus nephritis subtypes

Figure 1 Pathological features of lupus nephritis subtypes
Figure 3 The fat–intestine–kidney axis

Figure 3 The fat–intestine–kidney axis
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Renal manifestations in Fabry disease and therapeutic options

Renal manifestations in Fabry disease and therapeutic options
Figure 1 The structure of the glycocalyx

Figure 1 The structure of the glycocalyx
Figure 1 Pathologic features of obesity-related glomerulopathy (ORG)

Figure 1 Pathologic features of obesity-related glomerulopathy (ORG)

Similar presentations

Ads by Google